Julijana Kristl
Direttore/Membro del Consiglio presso KRKA, D. D.
Profilo
Julijana Kristl is currently an Independent Member-Supervisory Board at KRKA dd, a Member at American Chemical Society, a Member at The Controlled Release Society, a Member at Association De Pharmacie Galenique Industrielle, and a Member-Supervisory Board at KRKA Farmaceutici Milano SRL.
She formerly held the position of Vice Rector at the University of Ljubljana.
Dr. Kristl received her undergraduate and graduate degrees in 1981 and her doctorate in 1988 from the University of Ljubljana.
Posizioni attive di Julijana Kristl
| Società | Posizione | Inizio |
|---|---|---|
| KRKA, D. D. | Direttore/Membro del Consiglio | 01/01/2010 |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
The Controlled Release Society
 The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Corporate Officer/Principal | - |
| Association De Pharmacie Galenique Industrielle | Corporate Officer/Principal | - |
KRKA Farmaceutici Milano SRL
 KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Julijana Kristl
| Società | Posizione | Fine |
|---|---|---|
| University of Ljubljana | Corporate Officer/Principal | - |
Formazione di Julijana Kristl
| University of Ljubljana | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KRKA, D. D. | Health Technology |
| Aziende private | 4 |
|---|---|
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
The Controlled Release Society
The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Commercial Services |
| Association De Pharmacie Galenique Industrielle | |
KRKA Farmaceutici Milano SRL
KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Health Technology |
- Borsa valori
- Insiders
- Julijana Kristl